Circulating metabolites are biomarker candidates for stroke risk prediction as assed in a europe-wide population cohort (biomarcare)
Christian Schulte(Universität Hamburg), Tanja Zeller(Universität Hamburg), Stefan Blankenberg(Universität Hamburg), V. Salomaa(Finnish Institute for Health and Welfare), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Hugh Tunstall‐Pedoe(University of Dundee), Christa Meisinger(University of Augsburg), Allan Linneberg(Frederiksberg Hospital), Francisco Ojeda(Universidad Complutense de Madrid), Maurizio Ferrario(University of Insubria), Renate B. Schnabel(Universität Hamburg), Giovanni Veronesi(University of Insubria), Barbara Thorand(Helmholtz Zentrum München), T Joergensen(Frederiksberg Hospital), Wolfgang Köenig(German Centre for Cardiovascular Research)
Cited by 0
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k